Bionetix Therapeutics
Suwon
About Bionetix Therapeutics
Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2020)
- Website: bionetixrx.com
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Canonical: https://fsome.com/organization/bionetix-therapeutics-88711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.